Diagonal Bio AB (publ) (DIABIO.ST)
- Previous Close
0.0145 - Open
0.0148 - Bid 0.0138 x --
- Ask 0.0142 x --
- Day's Range
0.0145 - 0.0145 - 52 Week Range
0.0120 - 0.0170 - Volume
4,667,208 - Avg. Volume
6,225,678 - Market Cap (intraday)
17.617M - Beta (5Y Monthly) -1.83
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Diagonal Bio AB (publ) operates as a biotechnology company in Sweden. The company offers LAMPlify, a customized system for general laboratory use to identify the presence of specific genetic markers for, for example, fungi, viruses, or bacteria. It is also involved in the development of PANVIRAL, a universal in vitro diagnostic system, that offers the potential for rapid and accurate point-of-care diagnoses in various settings, such as doctor's office, surgery, mobile clinics, hospital bedsides, and workplaces and airports. The company was incorporated in 2020 and is based in Lund, Sweden.
diagonalbio.comRecent News: DIABIO.ST
View MorePerformance Overview: DIABIO.ST
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DIABIO.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DIABIO.ST
View MoreValuation Measures
Market Cap
15.79M
Enterprise Value
14.06M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
99.64
Price/Book (mrq)
0.59
Enterprise Value/Revenue
611.50
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-21.17%
Return on Equity (ttm)
-43.32%
Revenue (ttm)
1.12M
Net Income Avi to Common (ttm)
-9.93M
Diluted EPS (ttm)
-0.3000
Balance Sheet and Cash Flow
Total Cash (mrq)
818k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-9.99M